Table 1 Characteristics in complex chronic patients (N = 3594)
Baseline variables | With ICH (N = 161) | Without ICH (N = 3433) | P value |
|---|---|---|---|
Age (years) | 86.5 ± 8.7 | 84.3 ± 11.6 | 0.016 |
Sex (male), n (%) | 90 (55.9%) | 1895 (55.2%) | 0.861 |
Barthel score | 44.5 ± 39.9 | 47.7 ± 40.4 | 0.332 |
CHADsVASC score | 0.1 ± 0.7 | 0.1 ± 0.6 | 0.654 |
HASBLED score | 3.5 ± 0.8 | 3.3 ± 1.1 | 0.074 |
HBA1c | 4.0 ± 3.2 | 4.3 ± 4.0 | 0.281 |
Complex chronic patients | |||
Dementia cognitive impairment, n (%) | 38 (23.6%) | 720 (21.0%) | 0.424 |
Diabetes, n (%) | 58 (36.0%) | 1452 (42.3%) | 0.115 |
Atrial fibrillation, n (%) | 51 (31.7%) | 947 (27.6%) | 0.257 |
Hipercholesterolemia, n (%) | 89 (55.3%) | 1628 (47.4%) | 0.051 |
Ischemic cardiomyopathy, n (%) | 33 (20.5%) | 601 (17.5%) | 0.331 |
Peripheral vascular disease, n (%) | 17 (10.6%) | 289 (8.4%) | 0.342 |
Heart failure, n (%) | 34 (21.1%) | 913 (26.6%) | 0.123 |
Thromboembolism, n (%) | 13 (8.1%) | 281 (8.2%) | 0.960 |
Stroke or AIT, n (%) | 16 (9.9%) | 259 (7.5%) | 0.264 |
Chronic renal disease, n (%) | 36 (22.4%) | 857 (25.0%) | 0.455 |
Chronic liver disease, n (%) | 1 (0.6%) | 57 (1.7%) | 0.306 |
Neoplasia, n (%) | 18 (11.2%) | 851 (24.8%) | < 0.001 |
Medication use | |||
Oral anticoagulant treatment, n (%) | 54 (33.5%) | 996 (29.0%) | 0.217 |
Nonsteroidal antiinflammatory drugs, n (%) | 112 (69.6%) | 2611 (76.1%) | 0.060 |
Antiaggregants, n (%) | 103 (64.0%) | 1817 (52.9%) | 0.006 |
Statines, n (%) | 85 (52.8%) | 1921 (56.0%) | 0.622 |